Progranulin mutation analysis: Identification of one novel mutation in exon 12 associated with frontotemporal dementia
dc.contributor.author | Aswathy, PM | |
dc.contributor.author | Jairani, PS | |
dc.contributor.author | Raghavan, SK | |
dc.contributor.author | Verghese, J | |
dc.contributor.author | Gopala, S | |
dc.contributor.author | Srinivas, P | |
dc.contributor.author | Mathuranath, PS | |
dc.date.accessioned | 2017-03-10T03:28:17Z | |
dc.date.available | 2017-03-10T03:28:17Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Progranulin (PGRN) mutations account for an average of 15% of familial frontotemporal dementia (FTD) cases and 20% of total FTD cases worldwide. Here, we investigated the frequency of PGRN mutations in FTD patients (n = 116) from a clinical cohort of south India and detected one novel mutation located on exon 12 in a familial behavioral variant FTD patient (accounting for similar to 1% of total FTD cases and 6% of familial FTD cases). This mutation was found to introduce a premature termination codon and the prematurely terminated messenger RNA may probably undergo nonsense-mediated decay. In enzyme-linked immunosorbent assay, the proband showed significantly reduced level of plasma PGRN (28 ng/mL) compared with controls (150 +/- 38 ng/mL), which implicates haploinsufficiency as the pathogenic mechanism. (C) 2016 Elsevier Inc. All rights reserved. | |
dc.identifier.citation | 39 ,;- | en_US |
dc.identifier.uri | 10.1016/j.neurobiolaging.2015.11.026 | |
dc.identifier.uri | https://dspace.sctimst.ac.in/handle/123456789/10315 | |
dc.publisher | NEUROBIOLOGY OF AGING | |
dc.subject | Geriatrics & Gerontology; Neurosciences & Neurology | |
dc.title | Progranulin mutation analysis: Identification of one novel mutation in exon 12 associated with frontotemporal dementia |